Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3514 | 117-39-5 |
None
| Property | Value | Reference |
|---|---|---|
| Vd (Volume of distribution) | 0.12 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 11 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| fu (Fraction unbound in plasma) | 0.01 % | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 0.60 hours | Lombardo F, Berellini G, Obach RS |
| BA (Bioavailability) | 0.50 % |
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | 2.466 | Moderate | 0.78 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 10 | Moderate | 0.78 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 9.638 | 10^-6 cm/s | Moderate | 0.78 |
| dh-clint | Dog hepatocyte intrinsic clearance | 92.897 | uL/min/10^6 cells | Moderate | 0.78 |
| dppb | Dog plasma protein binding (% unbound) | 2.130 | % | Moderate | 0.78 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 0.690 | % | Moderate | 0.78 |
| herg | hERG pIC50 | 4.273 | pIC50 | Moderate | 0.78 |
| hh-clint | Human hepatocyte intrinsic clearance | 322.107 | uL/min/10^6 cells | Moderate | 0.78 |
| hlm-clint | Human liver microsomal intrinsic clearance | 29.785 | uL/min/mg protein | Moderate | 0.78 |
| hppb | Human plasma protein binding (% unbound) | 0.650 | % | Moderate | 0.78 |
| kinase-safety-class | AAK1,ACVR1B,ACVR2A,ACVR2B,ACVRL1,AKT3,ALK,AURKA,AURKB,AURKC,AXL,BLK,BMX,BRAF,BTK,CAMK2A,CAMK2B,CAMK2D,CAMK2G,CDK1,CDK14,CDK16,CDK19,CDK2,CDK3,CDK4,CDK5,CDK7,CDK9,CHUK,CLK4,CSF1R,CSNK1A1L,CSNK1D,CSNK1E,CSNK1G1,CSNK1G2,CSNK1G3,CSNK2A1,CSNK2A3,DDR1,DYRK1B,DYRK3,EGFR,EIF2AK3,EPHA2,EPHB3,EPHB4,ERBB2,FGFR1,FGFR4,FLT1,FLT3,FLT4,FYN,GRK2,GRK3,GSK3A,GSK3B,HASPIN,IGF1R,IKBKB,INSR,INSRR,IRAK1,IRAK3,ITK,JAK1,JAK2,JAK3,KDR,KIT,LCK,LYN,MAP2K4,MAP2K6,MAP3K1,MAP3K10,MAP3K11,MAP3K14,MAP3K2,MAP3K21,MAP3K3,MAP3K7,MAP3K8,MAP4K1,MAP4K2,MAP4K3,MAP4K5,MAPK1,MAPK10,MAPK12,MAPK14,MAPK7,MAPK8,MAPK9,MAPKAPK2,MARK2,MARK4,MELK,MET,MINK1,MTOR,NTRK1,NTRK2,PAK4,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM1,PIM2,PIM3,PRKAA1,PRKCD,PRKDC,PTK2,PTK6,RET,SGK1,SIK2,SIK3,SRC,STK10,STK17A,STK33,SYK,TBK1,TEK,TGFBR1,TNIK,TTK,TYRO3,UHMK1,ULK1,ULK2,YES1,ZAP70 | 142 | |||
| kinase-selectivity-class | AAK1,ACVR1B,ACVR2A,ACVR2B,ACVRL1,ALK,AURKA,AURKB,AURKC,AXL,BLK,BMX,BRAF,CAMK2A,CAMK2B,CAMK2D,CDK1,CDK16,CDK2,CDK3,CDK4,CDK6,CDK7,CDK9,CHEK1,CLK2,CLK4,CSF1R,CSNK2A2,DDR1,DYRK1B,DYRK2,DYRK3,EIF2AK3,EPHB4,ERBB2,FGFR1,FGFR4,FLT1,FLT3,FLT4,FYN,GRK2,GSK3A,GSK3B,HASPIN,HIPK2,INSR,IRAK1,IRAK3,JAK1,JAK2,JAK3,KDR,KIT,MAP2K3,MAP2K4,MAP2K6,MAP3K10,MAP3K11,MAP3K14,MAP3K2,MAP3K21,MAP3K7,MAP3K9,MAP4K1,MAP4K3,MAP4K5,MAPK1,MAPK10,MAPK12,MAPK7,MAPK8,MARK1,MARK2,MARK3,MARK4,MELK,MINK1,MKNK2,MTOR,NTRK1,PDGFRB,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIK3CG,PIM3,PLK1,PLK2,PLK3,PLK4,PRKAA1,PRKAA2,PRKCD,PRKCZ,PRKDC,PTK2,RET,RIPK1,RIPK3,SGK1,SIK2,SIK3,SRC,STK10,STK16,STK17A,STK33,SYK,TEK,TGFBR1,TNIK,TTK,TYRO3,ULK1,ULK2,YES1,ZAP70 | 120 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 41.305 | Moderate | 0.78 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 343.558 | Moderate | 0.78 | |
| mppb | Mouse plasma protein binding (% unbound) | 2.490 | Moderate | 0.78 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 3.373 | Moderate | 0.78 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 6.060 | % | Moderate | 0.78 |
| rh-clint | Rat hepatocyte intrinsic clearance | 279.898 | uL/min/10^6 cells | Moderate | 0.78 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 58.940 | % | Moderate | 0.78 |
| rppb | Rat plasma protein binding (% unbound) | 0.920 | % | Moderate | 0.78 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 0.776 | uM | Moderate | 0.78 |
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Drug ineffective for unapproved indication | 58.24 | 33.15 | 20 | 545 | 66624 | 90561258 |
None
None
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000975 | Antioxidants |
| MeSH PA | D020011 | Protective Agents |
| CHEBI has role | CHEBI:22586 | antioxidant |
| CHEBI has role | CHEBI:22587 | antiviral agent |
| CHEBI has role | CHEBI:33282 | antibacterial agent |
| CHEBI has role | CHEBI:35526 | hypoglycemic agent |
| CHEBI has role | CHEBI:35554 | cardiovascular drug |
| CHEBI has role | CHEBI:35610 | antineoplastic agent |
| CHEBI has role | CHEBI:37699 | protein kinase inhibitor |
| CHEBI has role | CHEBI:38161 | chelator |
| CHEBI has role | CHEBI:48578 | radical scavenger |
| CHEBI has role | CHEBI:66981 | ophthalmology drug |
| CHEBI has role | CHEBI:67079 | anti-inflammatory agent |
| CHEBI has role | CHEBI:70770 | Aurora kinase inhibitor |
| CHEBI has role | CHEBI:74518 | anti-obesity agent |
| CHEBI has role | CHEBI:75835 | anti-anaemic agent |
| CHEBI has role | CHEBI:76924 | plant metabolite |
| CHEBI has role | CHEBI:76989 | phytoestrogen |
| CHEBI has role | CHEBI:77020 | EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor |
| CHEBI has role | CHEBI:176497 | geroprotector |
| CHEBI has role | CHEBI:233423 | antifibrotic agent |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Primary hyperoxaluria | contraindication | 17901006 | DOID:2977 |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Anemia due to enzyme deficiency | contraindication | 111577008 | |
| Hb SS disease | contraindication | 127040003 | DOID:10923 |
| Hemochromatosis | contraindication | 399187006 | DOID:2352 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 6.4 | acidic |
| pKa2 | 9.56 | acidic |
| pKa3 | 11.29 | acidic |
| pKa4 | 14.0 | acidic |
| pKa5 | 14.0 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Myeloperoxidase | Enzyme | IC50 | 5.90 | CHEMBL | |||||
| Prostaglandin G/H synthase 2 | Enzyme | IC50 | 4.54 | CHEMBL | |||||
| Urokinase-type plasminogen activator | Enzyme | IC50 | 4.92 | CHEMBL | |||||
| Multidrug resistance protein 1 | Transporter | Kd | 5.15 | CHEMBL | |||||
| Adenosine receptor A3 | GPCR | Ki | 4.52 | CHEMBL | |||||
| D(4) dopamine receptor | GPCR | Ki | 5.11 | CHEMBL | |||||
| Carbonic anhydrase 2 | Enzyme | Ki | 5.60 | CHEMBL | |||||
| Multidrug resistance-associated protein 1 | Transporter | Ki | 5.62 | CHEMBL | |||||
| ATP-binding cassette sub-family G member 2 | Transporter | IC50 | 5.16 | CHEMBL | |||||
| Carbonic anhydrase 1 | Enzyme | Ki | 5.57 | CHEMBL | |||||
| Proto-oncogene tyrosine-protein kinase receptor Ret | Kinase | IC50 | 4.11 | CHEMBL | |||||
| Vascular endothelial growth factor receptor 2 | Kinase | IC50 | 6.55 | CHEMBL | |||||
| Dipeptidyl peptidase 4 | Enzyme | IC50 | 4.49 | CHEMBL | |||||
| Cytochrome P450 2C8 | Enzyme | IC50 | 5.46 | CHEMBL | |||||
| Calmodulin | Cytosolic other | IC50 | 4.89 | CHEMBL | |||||
| Carbonic anhydrase 4 | Enzyme | Ki | 5.10 | CHEMBL | |||||
| Acetylcholinesterase | Enzyme | Ki | 4.42 | CHEMBL | |||||
| Amine oxidase [flavin-containing] B | Enzyme | IC50 | 4.05 | CHEMBL | |||||
| Cholinesterase | Enzyme | Ki | 4.17 | CHEMBL | |||||
| Xanthine dehydrogenase/oxidase | Enzyme | IC50 | 5.58 | CHEMBL | |||||
| Amine oxidase [flavin-containing] A | Enzyme | IC50 | 5.55 | CHEMBL | |||||
| Aldose reductase | Enzyme | IC50 | 7.83 | CHEMBL | |||||
| Carbonic anhydrase 9 | Enzyme | Ki | 5.15 | CHEMBL | |||||
| Aromatase | Enzyme | IC50 | 7.92 | CHEMBL | |||||
| Carbonic anhydrase 12 | Enzyme | Ki | 5.03 | CHEMBL | |||||
| Arachidonate 5-lipoxygenase | Enzyme | IC50 | 6.10 | CHEMBL | |||||
| Prothrombin | Enzyme | Kd | 7.41 | CHEMBL | |||||
| Epidermal growth factor receptor | Kinase | IC50 | 6.05 | CHEMBL | |||||
| Vasopressin V2 receptor | GPCR | IC50 | 5.20 | CHEMBL | |||||
| Peroxisome proliferator-activated receptor gamma | Nuclear hormone receptor | IC50 | 4.58 | CHEMBL | |||||
| Carbonic anhydrase 5A, mitochondrial | Enzyme | Ki | 5.17 | CHEMBL | |||||
| Carbonic anhydrase 5B, mitochondrial | Enzyme | Ki | 4.92 | CHEMBL | |||||
| Carbonic anhydrase 7 | Enzyme | Ki | 5.32 | CHEMBL | |||||
| Tyrosine-protein phosphatase non-receptor type 1 | Enzyme | IC50 | 4.63 | CHEMBL | |||||
| Tyrosinase | Enzyme | IC50 | 4.35 | CHEMBL | |||||
| Pancreatic triacylglycerol lipase | Enzyme | IC50 | 5.82 | CHEMBL | |||||
| Maltase-glucoamylase, intestinal | Enzyme | IC50 | 4.97 | CHEMBL | |||||
| Proto-oncogene tyrosine-protein kinase Src | Kinase | IC50 | 6.92 | CHEMBL | |||||
| Tyrosine-protein kinase Lck | Kinase | IC50 | 4.89 | CHEMBL | |||||
| Tyrosine-protein kinase Yes | Kinase | Ki | 6.33 | CHEMBL | |||||
| Serine/threonine-protein kinase B-raf | Kinase | IC50 | 5.12 | CHEMBL | |||||
| Receptor-type tyrosine-protein kinase FLT3 | Kinase | IC50 | 6.23 | CHEMBL | |||||
| Aurora kinase B | Kinase | IC50 | 6.04 | CHEMBL | |||||
| 72 kDa type IV collagenase | Enzyme | IC50 | 5.18 | CHEMBL | |||||
| Cyclin-dependent kinase 1 | Kinase | IC50 | 6.35 | CHEMBL | |||||
| Cyclin-dependent kinase 2 | Kinase | IC50 | 4.40 | CHEMBL | |||||
| Serine/threonine-protein kinase pim-1 | Kinase | Kd | 7.60 | CHEMBL | |||||
| Insulin-like growth factor 1 receptor | Kinase | IC50 | 6.52 | CHEMBL | |||||
| Lactoylglutathione lyase | Enzyme | IC50 | 5.49 | CHEMBL | |||||
| Alpha-amylase 1 | Enzyme | IC50 | 4.67 | CHEMBL | |||||
| Histone deacetylase 6 | Enzyme | IC50 | 6.09 | CHEMBL | |||||
| Neutrophil elastase | Enzyme | Ki | 4.92 | CHEMBL | |||||
| Focal adhesion kinase 1 | Kinase | IC50 | 5.92 | CHEMBL | |||||
| Arachidonate 15-lipoxygenase | Enzyme | IC50 | 5.66 | CHEMBL | |||||
| Carbonic anhydrase 3 | Enzyme | Ki | 5.09 | CHEMBL | |||||
| Stromelysin-1 | Enzyme | IC50 | 5.25 | CHEMBL | |||||
| Serine/threonine-protein kinase PLK1 | Kinase | IC50 | 5.24 | CHEMBL | |||||
| Carbonic anhydrase 6 | Enzyme | Ki | 5.21 | CHEMBL | |||||
| Estradiol 17-beta-dehydrogenase 2 | Enzyme | IC50 | 5.81 | CHEMBL | |||||
| Tyrosine-protein kinase SYK | Kinase | IC50 | 4.70 | CHEMBL | |||||
| Prolyl endopeptidase | Enzyme | IC50 | 4.89 | CHEMBL | |||||
| Arachidonate 12-lipoxygenase, 12S-type | Enzyme | IC50 | 6.36 | CHEMBL | |||||
| Hepatocyte growth factor receptor | Kinase | IC50 | 6.24 | CHEMBL | |||||
| Serine/threonine-protein kinase Nek2 | Kinase | IC50 | 5.24 | CHEMBL | |||||
| Carbonic anhydrase 14 | Enzyme | Ki | 5.27 | CHEMBL | |||||
| Calcium/calmodulin-dependent protein kinase type II subunit beta | Kinase | IC50 | 5.52 | CHEMBL | |||||
| Matrix metalloproteinase-9 | Enzyme | IC50 | 5.79 | CHEMBL | |||||
| Serine/threonine-protein kinase N1 | Kinase | IC50 | 5.24 | CHEMBL | |||||
| Interstitial collagenase | Enzyme | Kd | 4.29 | CHEMBL | |||||
| Phospholipase A2 | Enzyme | IC50 | 5.70 | CHEMBL | |||||
| ALK tyrosine kinase receptor | Kinase | IC50 | 5.48 | CHEMBL | |||||
| RAC-alpha serine/threonine-protein kinase | Kinase | IC50 | 5.27 | CHEMBL | |||||
| Macrophage metalloelastase | Enzyme | IC50 | 4.99 | CHEMBL | |||||
| Collagenase 3 | Enzyme | IC50 | 5.07 | CHEMBL | |||||
| Chymotrypsinogen B | Enzyme | IC50 | 4 | CHEMBL | |||||
| Death-associated protein kinase 1 | Kinase | IC50 | 5.05 | CHEMBL | |||||
| Beta-secretase 1 | Enzyme | Ki | 4.85 | CHEMBL | |||||
| Glycogen synthase kinase-3 beta | Kinase | IC50 | 5.70 | CHEMBL | |||||
| Cystic fibrosis transmembrane conductance regulator | Ion channel | Kd | 4.59 | CHEMBL | |||||
| Bifunctional epoxide hydrolase 2 | Enzyme | IC50 | 4.47 | CHEMBL | |||||
| Glycogen phosphorylase, liver form | Enzyme | IC50 | 5.32 | CHEMBL | |||||
| Lysine--tRNA ligase | Enzyme | IC50 | 4.70 | CHEMBL | |||||
| C-C chemokine receptor type 4 | GPCR | IC50 | 5 | CHEMBL | |||||
| Cyclin-dependent kinase 6 | Kinase | IC50 | 4.60 | CHEMBL | |||||
| Aldo-keto reductase family 1 member B10 | Enzyme | IC50 | 5.72 | CHEMBL | |||||
| Tyrosine-protein kinase receptor UFO | Kinase | IC50 | 6.02 | CHEMBL | |||||
| C-X-C chemokine receptor type 1 | GPCR | IC50 | 5.35 | CHEMBL | |||||
| Casein kinase II subunit alpha | Kinase | Ki | 5.93 | CHEMBL | |||||
| NUAK family SNF1-like kinase 1 | Kinase | IC50 | 5.29 | CHEMBL | |||||
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Kinase | IC50 | 4.86 | CHEMBL | |||||
| G-protein coupled receptor 35 | GPCR | IC50 | 4.81 | CHEMBL | |||||
| Proteasome subunit beta type-5 | Enzyme | IC50 | 5.70 | CHEMBL | |||||
| Cytochrome P450 1B1 | Enzyme | IC50 | 7.11 | CHEMBL | |||||
| Phosphatidylinositol 3-kinase regulatory subunit alpha | Kinase | IC50 | 5.42 | CHEMBL | |||||
| NADPH oxidase 4 | Enzyme | IC50 | 6.17 | CHEMBL | |||||
| Lysine-specific histone demethylase 1A | Enzyme | IC50 | 5.90 | CHEMBL | |||||
| Serine/threonine-protein kinase Nek6 | Kinase | IC50 | 5.37 | CHEMBL | |||||
| Cyclin-dependent kinase 1/cyclin B1 | Kinase | IC50 | 4.70 | CHEMBL | |||||
| Cyclin-dependent kinase 5/CDK5 activator 1 | Kinase | IC50 | 4.64 | CHEMBL | |||||
| Cyclin-dependent kinase 1/cyclin B | Kinase | IC50 | 4.12 | CHEMBL | |||||
| Cyclin-dependent kinase 4/cyclin D1 | Kinase | IC50 | 4.21 | CHEMBL | |||||
| Glycogen synthase kinase-3 | Kinase | IC50 | 5.68 | CHEMBL | |||||
| Short transient receptor potential channel 5 | Ion channel | IC50 | 5.19 | CHEMBL | |||||
| Sorbitol dehydrogenase | Enzyme | IC50 | 4.45 | CHEMBL | |||||
| Chymotrypsin C | Enzyme | IC50 | 4 | CHEMBL | |||||
| Hypoxia-inducible factor 1-alpha inhibitor | Enzyme | IC50 | 4.99 | CHEMBL | |||||
| Lymphocyte differentiation antigen CD38 | Tumour-associated antigen | IC50 | 4.42 | CHEMBL | |||||
| Amyloid beta A4 protein | Membrane other | IC50 | 5.10 | CHEMBL | |||||
| Solute carrier organic anion transporter family member 2B1 | Transporter | IC50 | 5.14 | CHEMBL | |||||
| Cytochrome P450 1A1 | Enzyme | EC50 | 5.06 | CHEMBL | |||||
| Solute carrier family 2, facilitated glucose transporter member 2 | Transporter | IC50 | 4.92 | CHEMBL | |||||
| ELAV-like protein 3 | Cytosolic other | IC50 | 5.75 | CHEMBL | |||||
| ELAV-like protein 1 | Cytosolic other | IC50 | 5.85 | CHEMBL | |||||
| Alpha-ketoglutarate-dependent dioxygenase FTO | Enzyme | IC50 | 5.02 | CHEMBL | |||||
| DNA polymerase eta | Enzyme | IC50 | 4.80 | CHEMBL | |||||
| Alpha-synuclein | Transporter | IC50 | 4.70 | CHEMBL | |||||
| Inositol polyphosphate multikinase | Kinase | IC50 | 5.64 | CHEMBL | |||||
| Inositol hexakisphosphate kinase 2 | Kinase | IC50 | 6.16 | CHEMBL | |||||
| Alpha-amylase 1A | Enzyme | IC50 | 4.67 | CHEMBL | |||||
| NAD-dependent protein deacetylase sirtuin-6 | Enzyme | IC50 | 5.72 | CHEMBL | |||||
| Beta-lactamase | Enzyme | IC50 | 5.40 | CHEMBL | |||||
| Alcohol dehydrogenase [NADP(+)] | Enzyme | IC50 | 4.42 | CHEMBL | |||||
| Aldose reductase | Enzyme | IC50 | 4.30 | CHEMBL | |||||
| Cationic trypsin | Enzyme | IC50 | 5.15 | CHEMBL | |||||
| Xanthine dehydrogenase/oxidase | Enzyme | Ki | 5.92 | CHEMBL | |||||
| Aldose reductase | Enzyme | IC50 | 6 | CHEMBL | |||||
| Arachidonate 15-lipoxygenase | Enzyme | IC50 | 6.37 | CHEMBL | |||||
| Integrase | Enzyme | IC50 | 6.22 | CHEMBL | |||||
| Carbonic anhydrase 13 | Enzyme | Ki | 5.04 | CHEMBL | |||||
| Aldose reductase | Enzyme | IC50 | 5.55 | CHEMBL | |||||
| Adenosine receptor A1 | GPCR | Ki | 5.61 | CHEMBL | |||||
| Alcohol dehydrogenase [NADP(+)] | Enzyme | IC50 | 5.63 | CHEMBL | |||||
| Neuraminidase | Enzyme | IC50 | 5.11 | CHEMBL | |||||
| Arachidonate 5-lipoxygenase | Enzyme | IC50 | 6.70 | CHEMBL | |||||
| Adenosine receptor A2a | GPCR | Ki | 5.16 | CHEMBL | |||||
| Beta-lactamase | Enzyme | IC50 | 4.07 | CHEMBL | |||||
| Amine oxidase [flavin-containing] A | Enzyme | IC50 | 8 | CHEMBL | |||||
| Amine oxidase [flavin-containing] B | Enzyme | IC50 | 4.70 | CHEMBL | |||||
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Enzyme | IC50 | 4.70 | CHEMBL | |||||
| Enoyl-acyl-carrier protein reductase | Enzyme | Ki | 7.66 | CHEMBL | |||||
| Polyphenol oxidase 2 | Enzyme | IC50 | 4.51 | CHEMBL | |||||
| Aldo-keto reductase family 1 member C21 | Enzyme | Ki | 4.96 | CHEMBL | |||||
| Neuraminidase | Enzyme | IC50 | 5.66 | CHEMBL | |||||
| Sialidase | Enzyme | IC50 | 5.77 | CHEMBL | |||||
| Malate dehydrogenase | Enzyme | IC50 | 5.22 | CHEMBL | |||||
| 5'-nucleotidase | Enzyme | Ki | 7.34 | CHEMBL | |||||
| 3-oxoacyl-acyl-carrier protein reductase | Enzyme | IC50 | 5.27 | CHEMBL | |||||
| Beta-hydroxyacyl-ACP dehydratase; Fatty acid synthesis protein | Enzyme | IC50 | 5.82 | CHEMBL | |||||
| Replicase polyprotein 1ab | Enzyme | IC50 | 5.09 | CHEMBL | |||||
| Lactoperoxidase | Enzyme | IC50 | 5.21 | CHEMBL | |||||
| D-alanine--D-alanine ligase | Enzyme | Ki | 5.37 | CHEMBL | |||||
| Arginase | Enzyme | IC50 | 5.40 | CHEMBL | |||||
| Nitric oxide synthase, inducible | Enzyme | IC50 | 4.79 | CHEMBL | |||||
| Cell division protein kinase 5 | Kinase | EC50 | 4.20 | CHEMBL | |||||
| D-alanylalanine synthetase | Enzyme | IC50 | 4.70 | CHEMBL | |||||
| Phosphodiesterase 2A | Enzyme | IC50 | 4.09 | CHEMBL | |||||
| Cytosol aminopeptidase | Enzyme | IC50 | 4.46 | CHEMBL | |||||
| Glutathione reductase | Enzyme | IC50 | 4.31 | CHEMBL | |||||
| Replicase polyprotein 1ab | Enzyme | IC50 | 5.16 | CHEMBL | |||||
| Spike glycoprotein | Glycoprotein | IC50 | 4.08 | CHEMBL | |||||
| Solute carrier family 2, facilitated glucose transporter member 4 | Transporter | Ki | 4.80 | CHEMBL | |||||
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Enzyme | IC50 | 5.05 | CHEMBL | |||||
| NACHT, LRR and PYD domains-containing protein 3 | Cytosolic other | IC50 | 4.43 | CHEMBL |
| ID | Source |
|---|---|
| 4030654 | VUID |
| N0000182642 | NUI |
| 4030654 | VANDF |
| C0034392 | UMLSCUI |
| CHEBI:16243 | CHEBI |
| QUE | PDB_CHEM_ID |
| CHEMBL50 | ChEMBL_ID |
| DB04216 | DRUGBANK_ID |
| D011794 | MESH_DESCRIPTOR_UI |
| 5280343 | PUBCHEM_CID |
| 5346 | IUPHAR_LIGAND_ID |
| 9IKM0I5T1E | UNII |
| 9060 | RXNORM |
| 007403 | NDDF |
| 126144003 | SNOMEDCT_US |
| 52130006 | SNOMEDCT_US |
| 9IKM0I5T1E | INXIGHT DRUGS |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| JinXianLian Hepato-Enzyme Regulating Agent | HUMAN OTC DRUG LABEL | 4 | 87650-002 | EXTRACT | 515 mg | ORAL | unapproved drug other | 11 sections |